Vaccine clinical trials have been essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors that affect trial procedures are reviewed, with specific solutions to streamline the clinical trial process.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047247 | PMC |
http://dx.doi.org/10.1093/cid/ciac301 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!